Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
LakeShore Biopharma Co., Ltd
LSBCurrent price
2.59 USD
-0.56 USD (-17.78%)
Last closed
3.16 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
114 293 984 USD
Yield for 12 month
-60.70 %
1Y
3Y
5Y
10Y
15Y
LSB
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China. Address: Building No. 2, Beijing, China, 102629
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.19 USDP/E ratio
–Dividend Yield
–Current Year
+79 515 525 USD
Last Year
+95 293 711 USD
Current Quarter
+2 599 375 USD
Last Quarter
+3 302 380 USD
Current Year
+63 195 767 USD
Last Year
+74 027 347 USD
Current Quarter
+659 942 USD
Last Quarter
+2 619 240 USD
Key Figures LSB
1 year
3 years
5 years
10 years
EBITDA
-315 903 072 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.85 %
PEG Ratio
–
Return On Equity TTM
-65.99 %
Wall Street Target Price
4.19 USD
Revenue TTM
573 418 240 USD
Book Value
3.08 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
27.7 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.57 USD
Diluted Eps TTM
-0.57 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-75.59 %
Dividend Analytics LSB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LSB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
01.10.2024
Dividend Date
–
Stock Valuation LSB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.7295
Price Sales TTM
0.1993
Enterprise Value EBITDA
–
Price Book MRQ
1.3909
Financials LSB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LSB
For 52 weeks
1.88 USD
11.2 USD
50 Day MA
0.46 USD
Shares Short Prior Month
83 712
200 Day MA
0.6 USD
Short Ratio
1.07
Shares Short
7 960
Short Percent
0.06 %
BeatStart